GEZIELTE IMMUNKONJUGATE

European patent · EP2467165 · In force

Register entry

Publication number
EP2467165
Application number
EP10744911
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 13, 2010
Published
Jun 27, 2012
Granted
Jan 7, 2015
Protection ends at the latest
Aug 12, 2030
Next annual fee due
Aug 31, 2027
IPC classes
A61K 47/48 (2006.01)
C07K 16/00 (2006.01)
C07K 16/18 (2006.01)
C07K 16/40 (2006.01)
C07K 16/46 (2006.01)
A61K 39/00 (2006.01)
Priority
US 234584 P 17.08.2009
EP 10162410 10.05.2010
PCT application
PCT/EP2010/061810 13.08.2010
PCT publication
WO2011/020783 24.02.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Jul 2, 2021

    Address changed

    Owner
    Roche Glycart AG, Wagistrasse 18, 8952 Schlieren-Zuerich → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren

    Published in Swissreg on 02.07.2021

  7. Jan 7, 2015

    Granted

    Published in Swissreg on 07.01.2015

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.